Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02802293 · ClinicalTrials.gov registry record · NA

Treatment of Depression With Connectivity Guided Robotically Delivered rTMS

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT02802293 is a NA study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02802293, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine the clinical effects (if any) of connectivity-guided repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD) to provide clues about the ideal neural networks to target for more robust clinical outcomes, and to identify potential biomarkers of treatment response including changes in brain network connectivity.

Interventions

  • DEVICE repetitive transcranial magnetic stimulation
  • DEVICE robotic arm

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-08-17
Est. Completion 2021-03-23
Phase NA

What the Registry Record Tells You About NCT02802293

The ClinicalTrials.gov registry entry for NCT02802293 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation is the first listed.

NCT02802293 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02802293 about?

NCT02802293 is a clinical study titled "Treatment of Depression With Connectivity Guided Robotically Delivered rTMS". The purpose of this study is to determine the clinical effects (if any) of connectivity-guided repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD) to provide clues about the ideal neural networks to target for more robust clinical outcomes, and to ...

What is the current status of trial NCT02802293?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2017-08-17. Estimated completion is 2021-03-23.

What interventions are being tested in trial NCT02802293?

The interventions under investigation include: repetitive transcranial magnetic stimulation (DEVICE), robotic arm (DEVICE).

Who is sponsoring clinical trial NCT02802293?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.